Citation Impact
Citing Papers
Conserved N-terminal cysteine dioxygenases transduce responses to hypoxia in animals and plants
2019 StandoutScienceNobel
Strategy for Dual-Analyte Luciferin Imaging: In Vivo Bioluminescence Detection of Hydrogen Peroxide and Caspase Activity in a Murine Model of Acute Inflammation
2013 StandoutNobel
Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54
2003 Standout
An increased prevalence of thyroid disease in children with 22q11.2 deletion syndrome
2015
H2S Biogenesis by Human Cystathionine γ-Lyase Leads to the Novel Sulfur Metabolites Lanthionine and Homolanthionine and Is Responsive to the Grade of Hyperhomocysteinemia
2009
The genomic basis of the Williams – Beuren syndrome
2008
Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation — a tale of three gases!
2009
Acromegaly
2006 Standout
Nutritional Regulation of the Insulin-Like Growth Factors*
1994
Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline
2010
The GH, prolactin, ACTH and cortisol responses to Hexarelin, a synthetic hexapeptide, undergo different age-related variations
1997
Cystic fibrosis
2016 Standout
Gi-Coupled GPCR Signaling Controls the Formation and Organization of Human Pluripotent Colonies
2009 StandoutNobel
Spermidine/Spermine-N1-Acetyltransferase 2 Is an Essential Component of the Ubiquitin Ligase Complex That Regulates Hypoxia-inducible Factor 1α
2007 StandoutNobel
Co-Localization of Growth Hormone Secretagogue Receptor and NPY mRNA in the Arcuate Nucleus of the Rat
1999
Free insulin-like growth factors in human obesity
1995
Serum Insulin-Like Growth Factor I Reference Values for an Automated Chemiluminescence Immunoassay System: Results from a Multicenter Study
2003
A Selenium Analogue of Firefly D ‐Luciferin with Red‐Shifted Bioluminescence Emission
2012 StandoutNobel
Brain magnetic resonance imaging findings in the Opitz G/BBB syndrome: Extension of the spectrum of midline brain anomalies
1993
Cushing's syndrome
2015 Standout
Interaction of salbutamol with pyridostigmine and arginine on both basal and GHRH‐stimulated GH secretion in humans
1994
Syndrome‐specific growth charts for 22q11.2 deletion syndrome in Caucasian children
2012
The role of glucocorticoids in the regulation of growth hormone secretion Mechanisms and clinical significance
1992
An Expanded Set of Amino Acid Analogs for the Ribosomal Translation of Unnatural Peptides
2007 StandoutNobel
New insights into cystic fibrosis-related diabetes in children
2013
Diagnosis and management of medical problems in adults with Williams–Beuren syndrome
2007
Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith–Wiedemann and Simpson–Golabi–Behmel syndromes
1997
Chromosome 22q11.2 Deletion Syndrome (DiGeorge Syndrome/Velocardiofacial Syndrome)
2010
Pyridostigmine-mediated growth hormone release: evidence for somatostatin involvement.
1992
Short term pirenzepine treatment is ineffective in suppressing 24-h growth hormone secretion in type 1 diabetes mellitus
1993
Glutamate decarboxylase autoimmunity and growth hormone secretion in type I diabetes mellitus
1997
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Prevalence of High Body Mass Index in US Children and Adolescents, 2007-2008
2010 Standout
Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene
2000 StandoutNature
The Somatotropic Axis in Critical Illness: Effect of Continuous Growth Hormone (GH)-Releasing Hormone and GH-Releasing Peptide-2 Infusion1
1997
Neuroendocrine control of pulsatile growth hormone release in the human: relationship with gender
1998
Williams–Beuren Syndrome
2010 Standout
Ghrelin induces adiposity in rodents
2000 StandoutNature
A Ribosomopathy Reveals Decoding Defective Ribosomes Driving Human Dysmorphism
2017 StandoutNobel
Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22
1997
Leishmania major thialysine Nε‐acetyltransferase: Identification of amino acid residues crucial for substrate binding
2005
Monogenic Disorders of Puberty
2002
Presenting phenotype and clinical evaluation in a cohort of 22 Williams–Beuren syndrome patients
2007
Disabilities and cognition in children and adolescents with 22q11 deletion syndrome
2005
Effects of pyridostigmine on spontaneous and growth hormone‐releasing hormone stimulated growth hormone secretion in children on daily glucocorticoid therapy after liver transplantation
1991
Thiol dioxygenases: unique families of cupin proteins
2010
Radiation Therapy in the Multimodal Treatment Approach of Pituitary Adenoma
2002
A gene expression atlas of the central nervous system based on bacterial artificial chromosomes
2003 StandoutNature
A role for ghrelin in the central regulation of feeding
2001 StandoutNature
Evidence for Involvement of Endogenous Somatostatin in the Galanin-Induced Growth Hormone Secretion in Children
1990
Type 1 diabetes
2013 Standout
Depression in adolescence
2012 Standout
Sickle-cell disease
2010 Standout
Pyridostigmine treatment selectively amplifies the mass of GH secreted per burst without altering GH burst frequency, half-life, basal GH secretion or the orderliness of GH release
1997
Crystal structure of Homo sapiens thialysine Nϵ‐acetyltransferase (HsSSAT2) in complex with acetyl coenzyme A
2006
Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists
2011
Effect of Cholecalciferol as Adjunctive Therapy With Insulin on Protective Immunologic Profile and Decline of Residual β-Cell Function in New-Onset Type 1 Diabetes Mellitus
2012
Clinical features of 78 adults with 22q11 deletion syndrome
2005
Mammalian G Proteins and Their Cell Type Specific Functions
2005
IMPAIRED GROWTH HORMONE RESPONSE TO INSULIN‐INDUCED HYPOGLYCAEMIA IN OBESE PATIENTS: RESTORATION BLOCKED BY RITANSERIN AFTER FENFLURAMINE ADMINISTRATION
1990
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
1998 StandoutNature
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Extrahepatic complications of nonalcoholic fatty liver disease
2013
Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults.
1996
Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay.
1995
Effect of naloxone on the growth hormone response to clonidine in normal women during the mid-luteal phase
1989
CNS midline anomalies in the opitz G/BBB syndrome: Report on 12 Brazilian patients
1992
22q11.2 deletion syndrome
2015 Standout
Dual Defects in Pulsatile Growth Hormone Secretion and Clearance Subserve the Hyposomatotropism of Obesity in Man*
1991
Effect of two β2-agonist drugs, salbutamol and broxaterol, on the growth hormone response to exercise in adult patients with asthmatic bronchitis
1995
Hydrogen sulfide as a gasotransmitter
2010
Diabetes classification: grey zones, sound and smoke: Action LADA 1
2008
Adrenal secretion during major depression in 8- to 16-year-olds, I. Altered diurnal rhythms in salivary cortisol and dehydroepiandrosterone (DHEA) at presentation
1996
Glucocorticoids may inhibit growth hormone release by enhancing beta-adrenergic responsiveness in hypothalamic somatostatin neurons.
1993
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
The Metabolic Syndrome and Insulin-Like Growth Factor I Regulation in Adolescent Obesity1
1998
Ribosomal Synthesis of N-Methyl Peptides
2008 StandoutNobel
A Population-Based Study of the 22q11.2 Deletion: Phenotype, Incidence, and Contribution to Major Birth Defects in the Population
2003
Primary structure and subunit stoichiometry of F1-ATPase from bovine mitochondria
1985 StandoutNobel
Sulfite oxidase deficiency: Studies of a patient with mental retardation, dislocated ocular lenses, and abnormal urinary excretion of S-sulfo-l-cysteine, sulfite, and thiosulfate
1967
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Determination of the Tryptophan Content of Proteins by Ion Exchange Chromatography of Alkaline Hydrolysates
1972 StandoutNobel
Primary and secondary prevention of Type 1 diabetes
2012
Investigations on the Antiproliferative Effects of Amino Acid Antagonists Targeting for Aminoacyl‐tRNA Synthetases Part I ‐ The Antibacterial Effect
1989
The Stability of Cysteine and Cystine during Acid Hydrolysis of Proteins and Peptides
1970
D-Amino Acid Oxidase
1968
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Cysteine Oxygenase
1969 StandoutNobel
Comparative Effectiveness and Safety of Methods of Insulin Delivery and Glucose Monitoring for Diabetes Mellitus
2012
Update on cystic fibrosis-related diabetes
2013
Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing's disease before and after surgical cure.
1994
[61] Applications of amino acid analogs for studying co- and posttranslational modifications of proteins
1983
Investigations on the Antiproliferative Effects of Amino Acid Antagonists Targeting for Aminoacyl‐tRNA Synthetases Part II ‐ The Antileukemic Effect
1989
AnFgf8mouse mutant phenocopies human 22q11 deletion syndrome
2002 StandoutNobel
Evidence for possible nonspecific reactions between N-ethylmaleimide and proteins
1967
Oxygen-18 study of the enzymatic oxidation of cysteamine to hypotaurine
1966
Ribosomal Synthesis of Dehydroalanine-Containing Peptides
2006 StandoutNobel
Vitamin D and Immune Function
2013 Standout
Toward the experimental codon reassignment in vivo : protein building with an expanded amino acid repertoire
1999 Nobel
New Biarsenical Ligands and Tetracysteine Motifs for Protein Labeling in Vitro and in Vivo: Synthesis and Biological Applications
2002 StandoutNobel
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Bioactivation of Chemopreventive Selenocysteine Se-Conjugates and Related Amino Acids by Amino Acid Oxidases Novel Route of Metabolism of Selenoamino Acids
2001
Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research
2011
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Complementary roles of gasotransmitters CO and H2S in sleep apnea
2017 StandoutNobel
One Polypeptide with Two Aminoacyl-tRNA Synthetase Activities
2000 Science
Primary Structure of Somatostatin, A Hypothalamic Peptide That Inhibits the Secretion of Pituitary Growth Hormone
1973 StandoutNobel
The Amino Acid Composition of Some Purified Proteins
1964
Characteristics of the cysteinesulfinate-forming enzyme system in rat liver
1966
Comparison between Insulin-Induced Hypoglycemia and Growth Hormone (GH)-Releasing Hormone + Arginine as Provocative Tests for the Diagnosis of GH Deficiency in Adults1
1998
A Specific and Sensitive Assay for Disulfides
1968
Metal–Organic Frameworks in Biomedicine
2011 Standout
Enzymatic aminoacylation of tRNA with unnatural amino acids
2006 StandoutNobel
Trends in Obesity Prevalence Among Children and Adolescents in the United States, 1988-1994 Through 2013-2014
2016 Standout
Systemic and Local Regulation of the Growth Plate
2003
Nonorthologous replacement of lysyl-tRNA synthetase prevents addition of lysine analogues to the genetic code
2003
The Reliability of Molecular Weight Determinations by Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis
1969 Standout
The structural basis of cysteine aminoacylation of tRNA Pro by prolyl-tRNA synthetases
2003 StandoutNobel
Assessment of Child and Adolescent Overweight and Obesity
2007
Ribosomal Synthesis of Unnatural Peptides
2005 StandoutNobel
Organoselenium and Organotellurium Compounds: Toxicology and Pharmacology
2004 Standout
Pseudohypoparathyroidism: Diagnosis and Treatment
2011
SMART, a simple modular architecture research tool: Identification of signaling domains
1998 Standout
Works of Marco Cappa being referenced
Selenalysine and protein synthesis
1976
REDUCED GROWTH HORMONE RESPONSE TO GROWTH HORMONE‐RELEASING HORMONE IN CHILDREN WITH SIMPLE OBESITY: EVIDENCE FOR SOMATOMEDIN‐C MEDIATED INHIBITION
1987
Further delineation of the Simpson‐Golabi‐Behmel (SGB) syndrome
1992
Raised C‐reactive protein levels in patients with recent onset type 1 diabetes
2006
Failure of pyridostigmine to increase both basal and GHRH-induced GH secretion in the night
1990
The opitz syndrome: A new designation for the clinically indistinguishable BBB and G syndromes
1987
Recombinant Human GH Replacement Therapy in Children with Pseudohypoparathyroidism Type Ia: First Study on the Effect on Growth
2010
Growth Hormone-Releasing Hormone Resistance in Pseudohypoparathyroidism Type Ia: New Evidence for Imprinting of the Gsα Gene
2003
Auxological evaluation in patients with DiGeorge/velocardiofacial syndrome (deletion 22q11.2 syndrome)
2001
Pyridostigmine Potentiates L-Dopa- but not Arginine- and Galanin-Induced Growth Hormone Secretion in Children
1990
Thyroid Morphology and Subclinical Hypothyroidism in Children and Adolescents with Williams Syndrome
2006
Simpson‐Golabi‐Behmel syndrome: An X‐linked encephalo‐trophoschisis syndrome
1988
Effect of the enhancement of the cholinergic tone by pyridostigmine on the exercise-induced growth hormone release in man
1993
Exogenous growth hormone administration does not inhibit the growth hormone response to hexarelin in normal men
1995
Pyridostigmine counteracts the blunted growth hormone response to growth hormone-releasing hormone of obese children
1989
Adrenal Steroidogenic Defects in Children with Precocious Pubarche
1992
PYRIDOSTIGMINE DOES NOT REVERSE DEXAMETHASONE‐INDUCED GROWTH HORMONE INHIBITION
1990
McCune-Albright Syndrome: A Clinical Longitudinal Study of 32 Patients
1999
Clinical effects of early treatment with insulin glargine in patients with cystic fibrosis and impaired glucose tolerance
2006
The growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, in short normal and obese children and in hypopituitary subjects.
1995
Basal insulin supplementation in Type 1 diabetic children: A long-term comparative observational study between continuous subcutaneous insulin infusion and glargine insulin
2007
Albuminuria and insulin resistance in children with biopsy proven non-alcoholic fatty liver disease
2009
Molecular Analysis of the GNAS1 Gene for the Correct Diagnosis of Albright Hereditary Osteodystrophy and Pseudohypoparathyroidism
2003
Influence of gender and pubertal stage at diagnosis on growth outcome in childhood thyrotoxicosis: results of a collaborative study
2005
Selenaproline and protein synthesis
1977
Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children.
1996
β-Selenaproline as competitive inhibitor of proline activation
1980
Oxidation of Se-Carboxymethyl-selenocysteine by L-aminoacid oxidase and by D-aspartate oxidase
1976
Simpson‐golabi‐behmel syndrome: An X‐linked encephalo‐tropho‐schisis syndrome
2013
Pituitary-ovarian responses to leuprolide acetate testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
1996
A study of growth hormone release in man after oral administration of amino acids
1981
Radioautographic detection of metabolites of 35S-dl-cystine
1960
Column chromatography of some sulfur-containing amino acids
1965
The specificity of cysteamine oxygenase
1975
Thiaisoleucine and protein synthesis
1979
Autoimmune Thyroid Diseases in Children
2010
The role of sulphur, sulphide and reducible dyes in the enzymic oxidation of cysteamine to hypotaurine
1965
Spectrophotometric determination of thiols and disulfides with N-ethylmaleinimide
1966
Current Concepts in Tall Stature and Overgrowth Syndromes
2001
Inhibitory effect of mercaptoethanol and hypotaurine on the desulfhydration of cysteine by cystathionase
1962
The effect of hexarelin on growth hormone (GH) secretion in patients with GH deficiency.
1995
Thialysine utilization by E. coli and its effects on cell growth
1982
Action of thiazolidine-2-carboxylic acid, a proline analog, on protein synthesizing systems
1979
No Protective Effect of Calcitriol on β-Cell Function in Recent-Onset Type 1 Diabetes
2010
Amino-Acid Composition of Hæmoglobin from Thunnus thynnus
1958 Nature
The Growth Hormone Response to Hexarelin in Children: Reproducibility and Effect of Sex Steroids1
1997
Prolactinomas in Children and Adolescents. Clinical Presentation and Long-Term Follow-Up
1998
Pyridostigmine potentiates growth hormone (GH)-releasing hormone-induced GH release in both men and women.
1993
A Novel Mutation inRPL10(Ribosomal Protein L10) Causes X-Linked Intellectual Disability, Cerebellar Hypoplasia, and Spondylo-Epiphyseal Dysplasia
2015
NALOXONE INHIBITS EXERCISE‐INDUCED RELEASE OF PRL AND GH IN ATHLETES
1983